Analysis

High costs has caused a shift in how both providers and consumers view health care.

Roughly 70 percent of the 442 generic drugs approved by the FDA in 2019 remain unavailable to consumers.

A lot of the blame is being laid at the feet of high-deductible health plans and coinsurance.

Between 2016 and 2018, increasing hospital spending added $43 billion to health insurers' costs.

Only 18 percent of benefits leaders say their benefits programs are at the front of the pack, and even more say they're falling behind.

Maybe it's time to rethink the fractured systems used to keep track of health care providers.